Introduction: Ischemic heart disease, which used to be infrequent in African countries, has become a leading cause of cardiovascular morbidity. Objectives: To determine the frequency of cardiovascular risk factors, to calculate the level of cardiovascular risk in patients with ischemic heart disease, and to compare the calendar age and vascular age of these patients. Patients and methods: This is a descriptive and analytical study conducted from July 2017 to May 2021 in the cardiology department of Kara University Hospital and included records of patients hospitalized for ischemic heart disease. The different cardiovascular risk factors were analyzed allowing to determine the vascular age and the global cardiovascular risk of these patients before their stroke. Results: The hospital incidence of ischemic heart disease was 3.2%. There was a discrete female predominance (men/women=45/51). High blood pressure (65.6%) was the most associated risk factor, followed by metabolic syndrome (42.7%), dyslipidemia (36.5%) and diabetes (28.1%). The mean vascular age was 69.2±13.1 years compared with 59.8±12.3 years of vital age, corresponding to a difference of 9.4 years. This mean difference was higher in the younger age group under 60 years (13.1 years) and in women (11.1 years). Before their stroke, the overall high cardiovascular risk (≥20%) of having a cardiovascular event at 10 years in these patients was 26.1% for the WHO abacus versus 53.1% for the Framingham score. Conclusion: The overall high cardiovascular risk of patients with ischemic heart disease was very high before their stroke. Similarly, the difference between the vascular age and the vital statistics age is significant, reflecting the early arterial aging of these patients.
Published in | Cardiology and Cardiovascular Research (Volume 5, Issue 4) |
DOI | 10.11648/j.ccr.20210504.21 |
Page(s) | 225-229 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Ischemic Heart Disease, Vascular Age, Cardiovascular Risk
[1] | Mendis S, Puska P, Norrving B. Global Atlas on Cardiovascular Disease Prevention and Control. 1-155. Genève (CH): Organisation mondiale de la santé; 2011. |
[2] | Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34: 2949-3003. |
[3] | Michelle DEKER. Avancées dans l’ischémie myocardique et l’insuffisance cardiaque-Focus sur le patient diabétique, Neuilly. Cardiol pratique. 2020. |
[4] | Kimbally-Kaky G, Bouramoue C. Profil et avenir des patients Congolais atteints d’insuffisance coronarienne à propos de 743 cas. Médecine d’Afrique noire; 2000 (47): 197-203. |
[5] | Ticolat P, Bertrand E, Barabe P. Aspects épidémiologiques de la maladie coronaire chez le noir africain: à propos de 103 cas. Résultats de l’enquête multicentrique CORONAFRIC. Cardiol Trop. 1991; 17: 7-20. |
[6] | Ba A. Epidémiologie de la coronaropathie en Afrique. Congrès APPAC, nov. 2017. Biarritz. https://www.google.com/search? Epidémiologie-de-la-coronaropathie-en-Afrique/. |
[7] | World Health Organization (WHO). Prevention of Cardiovascular Disease, Pocket Guidelines for Assessement and Management of Cardiovascular Risk; Geneva 2007. |
[8] | D’Agostino B, Ramachandran S, Michael J, Philip A, Mark C, Joseph M, William B. General Cardiovascular Risk Profile for Use in Primary Care: the Framingham Heart Study. Circulation. 2008; 117: 743-753. |
[9] | Berriche O, Romdhane W, Arfa S et al. Cardiopathie ischémique chez les patients diabétiques: à propos d’une série de 100 diabétiques. Annales d’Endocrinologie. 2021, 82 (5): p 508. |
[10] | ATP III Guidelines At-A-Glance Quick Desk Reference; National Cholesterol Education Program. US Departement of Health and Human Services. NIH Publication N° 01-3304, may 2001. |
[11] | World Health Organization (WHO). BMI Classification 2004. http://www.who.int/bmi/index.jsp?intro Page=intro_3.html. |
[12] | David A, Lellouche N. KB Cardiologie: Cardiologie vasculaire. 8e éd. Paris: VG; 2018, 734p. 10, 24-25, 88-91, 113-158. |
[13] | Ferrières J, Cambou JP. Épidémiologie du syndrome coronaire aigu en France. Annales de Cardiologie et d'Angéiologie. 2007; 56 (1): 8-15. |
[14] | Roth GA, Johnson C, Abajobir A, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol 2017; 70: 1-25. |
[15] | Damorou F, Yayehd K, Pessinaba S, Baragou R, Soussou B. Les cardiopathies ischémiques (CI) à Lomé: aspects épidémiologiques et facteurs de risques (étude de 461 cas). Mali Méd. 2008, 23 (3), 47-54. |
[16] | Hdidou Y, Aynaou H, Latrech H. La cardiopathie ischémique chez les diabétiques de type 2: à propos de 51 patients (Oujda, Maroc). Diabetes and Metabolism. 2014; 40: 38-39. |
[17] | Diarra M. B, Diarra A, Sanogo K, Diakité S, Tchintchui N, Diall I, Diallo B. A, Toure M. K. Cardiopathies ischémiques en Cardiologie à Bamako (à propos de 162 cas). Mali Méd; 2007. 22 (4): 36-39. |
[18] | Barthelemy O, Jacqueminet S, Rouzet F. Intensive cardiovascular risk factors therapy and prevalence of silent myocardial ischaemia in patients with type 2 diabetes. Arch cardiovasc Dis. 2008; 101 (9): 539-46. |
[19] | Thiam M, Cloatre G, Fall F, Thébald X, Perret J. Cardiopathies ischémiques en Afrique, expérience de l’Hôpital Principal de Dakar. MAN; 2000, 47: 282-284. |
[20] | Samadoulougou A, Lengani A, Zabsonre P, Kabore J. P, Toguyeni B, Nebie L, Niakara A, Sanou B, Tega Y. Aspects épidémiologiques, cliniques et évolutifs des cardiopathies ischémiques dans le service de cardiologie du centre hospitalier universitaire Yalgado Ouedraogo à Ouagadougou. MAN. 2011; 58 (1): 14-18. |
[21] | Houénassi D, Tchabi Y, Awanou B, Véhounkpé-Sacca J, Akindès-Dossou Yovo R, Sehonou J, Atadokpédé F, Hounto F, Lawani R, Gnangnon A, d’Almeida-Massougbodji M, Agboton H. Évolution du risque cardiovasculaire des patients traités pour HTA à l’hôpital d’instruction des armées de Cotonou. Annales de Cardiologie et d’Angéiologie 2013; 62: 12–16. |
[22] | Munyapara SA, Mundu MG, Kakudji IL. Evaluation du risque cardiovasculaire global des patients hypertendus suivis dans les centres médicaux militaires de Kinshasa, RDC. Kisangani Médical 2015; 6 (1): 117-23. |
[23] | Bruckert E, Bonnelye G, Thomas-Delecourt F et al. Evaluation du risque cardiovasculaire en médecine générale en France. Archives of Cardiovascular Disease 2011; 104: 381-387. |
[24] | Simon A, Mijiti W, Gariepy J et al. Current possibilities for detecting high risk of cardiovascular disease. International Journal of Cardiology 2006; 110 (2): 146-52. |
APA Style
Machihude Pio, Tchaa Tcherou, Doguénsaga Borgotia Atta, Lihanimpo Djalogue, Abalo Mario Bakai, et al. (2021). Global Cardiovscular Risk and Vascular Age in Patients with Ischemic Cardiopatia at the Kara University Hospital (Kara-U H). Cardiology and Cardiovascular Research, 5(4), 225-229. https://doi.org/10.11648/j.ccr.20210504.21
ACS Style
Machihude Pio; Tchaa Tcherou; Doguénsaga Borgotia Atta; Lihanimpo Djalogue; Abalo Mario Bakai, et al. Global Cardiovscular Risk and Vascular Age in Patients with Ischemic Cardiopatia at the Kara University Hospital (Kara-U H). Cardiol. Cardiovasc. Res. 2021, 5(4), 225-229. doi: 10.11648/j.ccr.20210504.21
AMA Style
Machihude Pio, Tchaa Tcherou, Doguénsaga Borgotia Atta, Lihanimpo Djalogue, Abalo Mario Bakai, et al. Global Cardiovscular Risk and Vascular Age in Patients with Ischemic Cardiopatia at the Kara University Hospital (Kara-U H). Cardiol Cardiovasc Res. 2021;5(4):225-229. doi: 10.11648/j.ccr.20210504.21
@article{10.11648/j.ccr.20210504.21, author = {Machihude Pio and Tchaa Tcherou and Doguénsaga Borgotia Atta and Lihanimpo Djalogue and Abalo Mario Bakai and Bénédicte Souho and Yaovi Mignazonzon Afassinou and Soulemane Pessinaba and Wiyaou Dieu-Donné Kaziga}, title = {Global Cardiovscular Risk and Vascular Age in Patients with Ischemic Cardiopatia at the Kara University Hospital (Kara-U H)}, journal = {Cardiology and Cardiovascular Research}, volume = {5}, number = {4}, pages = {225-229}, doi = {10.11648/j.ccr.20210504.21}, url = {https://doi.org/10.11648/j.ccr.20210504.21}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20210504.21}, abstract = {Introduction: Ischemic heart disease, which used to be infrequent in African countries, has become a leading cause of cardiovascular morbidity. Objectives: To determine the frequency of cardiovascular risk factors, to calculate the level of cardiovascular risk in patients with ischemic heart disease, and to compare the calendar age and vascular age of these patients. Patients and methods: This is a descriptive and analytical study conducted from July 2017 to May 2021 in the cardiology department of Kara University Hospital and included records of patients hospitalized for ischemic heart disease. The different cardiovascular risk factors were analyzed allowing to determine the vascular age and the global cardiovascular risk of these patients before their stroke. Results: The hospital incidence of ischemic heart disease was 3.2%. There was a discrete female predominance (men/women=45/51). High blood pressure (65.6%) was the most associated risk factor, followed by metabolic syndrome (42.7%), dyslipidemia (36.5%) and diabetes (28.1%). The mean vascular age was 69.2±13.1 years compared with 59.8±12.3 years of vital age, corresponding to a difference of 9.4 years. This mean difference was higher in the younger age group under 60 years (13.1 years) and in women (11.1 years). Before their stroke, the overall high cardiovascular risk (≥20%) of having a cardiovascular event at 10 years in these patients was 26.1% for the WHO abacus versus 53.1% for the Framingham score. Conclusion: The overall high cardiovascular risk of patients with ischemic heart disease was very high before their stroke. Similarly, the difference between the vascular age and the vital statistics age is significant, reflecting the early arterial aging of these patients.}, year = {2021} }
TY - JOUR T1 - Global Cardiovscular Risk and Vascular Age in Patients with Ischemic Cardiopatia at the Kara University Hospital (Kara-U H) AU - Machihude Pio AU - Tchaa Tcherou AU - Doguénsaga Borgotia Atta AU - Lihanimpo Djalogue AU - Abalo Mario Bakai AU - Bénédicte Souho AU - Yaovi Mignazonzon Afassinou AU - Soulemane Pessinaba AU - Wiyaou Dieu-Donné Kaziga Y1 - 2021/12/29 PY - 2021 N1 - https://doi.org/10.11648/j.ccr.20210504.21 DO - 10.11648/j.ccr.20210504.21 T2 - Cardiology and Cardiovascular Research JF - Cardiology and Cardiovascular Research JO - Cardiology and Cardiovascular Research SP - 225 EP - 229 PB - Science Publishing Group SN - 2578-8914 UR - https://doi.org/10.11648/j.ccr.20210504.21 AB - Introduction: Ischemic heart disease, which used to be infrequent in African countries, has become a leading cause of cardiovascular morbidity. Objectives: To determine the frequency of cardiovascular risk factors, to calculate the level of cardiovascular risk in patients with ischemic heart disease, and to compare the calendar age and vascular age of these patients. Patients and methods: This is a descriptive and analytical study conducted from July 2017 to May 2021 in the cardiology department of Kara University Hospital and included records of patients hospitalized for ischemic heart disease. The different cardiovascular risk factors were analyzed allowing to determine the vascular age and the global cardiovascular risk of these patients before their stroke. Results: The hospital incidence of ischemic heart disease was 3.2%. There was a discrete female predominance (men/women=45/51). High blood pressure (65.6%) was the most associated risk factor, followed by metabolic syndrome (42.7%), dyslipidemia (36.5%) and diabetes (28.1%). The mean vascular age was 69.2±13.1 years compared with 59.8±12.3 years of vital age, corresponding to a difference of 9.4 years. This mean difference was higher in the younger age group under 60 years (13.1 years) and in women (11.1 years). Before their stroke, the overall high cardiovascular risk (≥20%) of having a cardiovascular event at 10 years in these patients was 26.1% for the WHO abacus versus 53.1% for the Framingham score. Conclusion: The overall high cardiovascular risk of patients with ischemic heart disease was very high before their stroke. Similarly, the difference between the vascular age and the vital statistics age is significant, reflecting the early arterial aging of these patients. VL - 5 IS - 4 ER -